A detailed history of Kilter Group LLC transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Kilter Group LLC holds 37 shares of BHC stock, worth $233. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37
Holding current value
$233
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

BUY
$4.32 - $6.66 $159 - $246
37 New
37 $247,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.28B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Kilter Group LLC Portfolio

Follow Kilter Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kilter Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kilter Group LLC with notifications on news.